[Therapy of inflammatory rheumatic diseases: from current practice standards to future].
Gause
A
A
Poliklinik für Rheumatologie Universitätsklinikum Lübeck, Ratzeburger Allee 160, 23538 Lübeck. Gause2@medinf.mu-luebeck.de
Manger
B
B
Kalden
J R
JR
Burmester
G R
GR
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001168:Arthritis / Q000188:drug therapy; D005858:Germany; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy*; D017410:Practice Guidelines as Topic; D016032:Randomized Controlled Trials as Topic; D012074:Remission Induction / Q000379:methods; D012216:Rheumatic Diseases / Q000188:drug therapy*; D013167:Spondylitis, Ankylosing / Q000188:drug therapy; D014657:Vasculitis / Q000188:drug therapy*
D000900:Anti-Bacterial Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal; D000964:Antimetabolites, Antineoplastic; D018501:Antirheumatic Agents; D005938:Glucocorticoids; D007166:Immunosuppressive Agents